Researcher in lab

Find clinical trials

Our clinical trial portfolio is one of the largest in the country. We have more than 600 clinical trials open across 30 clinical units.

Find Melbourne Sexual Health Centre research studies and clinical trials
Clear filter
604 clinical trials found
Clinical trials

REVERS-PVD

Unravelling the reversibility of pulmonary vascular disease in HFpEF, aortic stenosis and CTEPH after intervention: the REVERS-PVD study (Trial Not Registered)

Currently recruiting

REVISE

Re-EValuating the Inhibition of Stress Erosions and prophylaxis against gastrointestinal bleeding in the critically ill (REVISE) trial (NCT03374800)

Recently completed/closed

REVIVE

A phase 2b, multinational, randomized, double-blind study to investigate the efficacy and safety of redasemtide (S-005151) compared with placebo in adult participants with acute ischemic stroke who are not eligible for tissue plasminogen activator or thrombectomy (NCT05953480)

Currently recruiting

RIBFIX_ADVANTAGE

Evaluation of the RibFix™ Advantage Rib Fixation System for Surgical Repair of Rib Fractures (Trial Not Registered)

Currently recruiting

RIBFIX_BLU

Prospective Multi-Centre comparative study of RibFix Blu Thoracic Fixation System versus non-surgical treatment in non-flail chest rib fractures (NCT05146986)

Currently recruiting

RIN-PF-302

An Open-label Extension Study of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (NCT04905693)

Currently recruiting

RLY-2608-101

A First-in-Human Study of Mutant-selective PI3Ka Inhibitor, RLY-2608, as a Single Agent in Advanced Solid Tumor Patients and in Combination With Fulvestrant in Patients With Advanced Breast Cancer (NCT05216432)

Currently recruiting

ROCKET

Reduction Of Chronic Post-surgical Pain with Ketamine - ROCKet Trial (ACTRN12617001619336)

No longer recruiting

ROCKET-ASCEND

A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND) (NCT05882877)

Currently recruiting

ROCKET-HORIZON

A Phase 3, Randomized, 24-week, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) (NCT05651711)

Recently completed/closed

ROSETTA

Red Blood Cell Transfusion in ECMO - a feasibility trial (NCT05814094)

No longer recruiting

RPC01-3201

INDUCTION STUDY #1 - A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND,PLACEBO-CONTROLLED STUDY OF ORAL OZANIMOD AS INDUCTION THERAPY FOR MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE (NCT03440372)

Currently recruiting

RPC01-3202

A Phase 3, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn’s Disease (Celgene 3202) (NCT03440385)

Currently recruiting

RPC01-3203

A Phase 3, multicentre, randomized, double-blind, placebo controlled study of oral ozanimod as maintenance therapy for moderately to severely active Crohn’s disease (RPC01-3203) (NCT03464097)

Currently recruiting

RPC01-3204

A Phase 3, Multicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease (NCT03467958)

Currently recruiting

S-BAN

Evaluating the effectiveness of sodium butyrate for treatment of anorexia nervosa in individuals aged 16 and over - an open-label proof of concept study (ACTRN12624000368538p)

Currently recruiting

SABR-COMET 10

A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of 4-10 Oligometastatic Tumors (SABR-COMET 10) (NCT03721341)

No longer recruiting

SABR-COMET 3

A phase III randomised controlled trial and economic evaluation of Stereotactic Ablative Radiotherapy (SABR) of Comprehensive treatment of OligoMETastatic (1-3 metastases) cancer. (NCT03862911)

Currently recruiting

SAD-AF

Selective Serotonin Reuptake Inhibitors And Depression in Atrial Fibrillation (SAD-AF) (ACTRN12623000227695p)

Currently recruiting

SAFER-TAVI

Secondary Access - FEmoral or radial in Transcatheter Aortic Valve Implantation TAVI? (NCT06284837)

Currently recruiting
23 24 25 26 27